Clinical Trial Update: A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab [Phase 4]

View source ↗

Summary

Phase 4 study evaluating B cell levels in infants of lactating women with clinically isolated syndrome or multiple sclerosis who are receiving ocrelizumab; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Multiple Sclerosis

Drugs mentioned

• Ocrevus (ocrelizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Multiple Sclerosis, Clinically Isolated Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2025-04-16